@article{3031006, title = "Joint ESH excellence centers' national meeting on renal sympathetic denervation: A Greek experts' survey", author = "Doumas, Michael and Andreadis, Emmanouil and Andronoglou, Markos and and Davlouros, Periklis and Dimitriadis, Kyriakos and Gkaliagkousi, Eugene and and Grassos, Harris and Hatzitolios, Apostolos and Iliakis, Panagiotis and and Kalaitzidis, Rigas and Kallistratos, Emmanouil and Kasiakogias, and Alexandros and Konstantinidis, Dimitrios and Kotsis, Vasilios and and Makris, Thomas and Manolis, Athanasios and Moulias, Athanasios and and Marketou, Maria and Papadakis, Ioannis and Papadopoulos, Dimitrios and and Poulimenos, Leonidas and Sanidas, Elias and Sarafidis, Pantelis and and Savopoulos, Christos and Stergiou, George and Tatakis, Fotis and and Thomopoulos, Konstantinos and Triantafyllidi, Helen and Triantafyllou, and Areti and Vlachakos, Dimitrios and Zebekakis, Pantelis and Ziakas, and Antonios and Papademetriou, Vasilios and Tsioufi, Costas and Task Force and Greek ESH Excelle", journal = "Ελληνική καρδιολογική επιθεώρηση", year = "2021", volume = "62", number = "5", pages = "355-358", publisher = "HELLENIC CARDIOLOGICAL SOC", issn = "1011-7970", doi = "10.1016/j.hjc.2021.04.003", keywords = "renal denervation; hypertension; safety; efficacy; Greek hypertension experts", abstract = "Objective: The efficacy of renal sympathetic denervation (RDN) has been affirmed by a number of recent clinical studies, despite controversies in this field over the last five years. Therefore, it is of paramount importance that hypertension experts debate the merits of RDN by revealing and expressing their personal beliefs and perspectives regarding this procedure. Methods: A cross-sectional survey was conducted among Greek leaders of the Hypertension Excellence Centers with the use of a closed-type questionnaire specifically designed to elicit information and evaluate the respondent’s views and perspectives about RDN efficacy, safety and ideal target patient population. Results: A total of 36 participants completed the survey. Based on the results, RDN was considered efficient (91.7%) and safe (94.5%), while the overwhelming majority of the participants felt confident in the long-term efficacy (88.9%) of the intervention and that it lacks reliable predictors of blood pressure response (94.5%). Patients with resistant (91.7%), ultra-resistant (94.4%), and uncontrolled hypertension (80.6%) were suggested as ideal candidates for RDN. Establishing a close co-operation between interventionalists and hypertension experts was considered essential to ensure the efficacy (97.2%) as well as the safety (97.3%) of the procedure. Conclusion: The vast majority of Greek hypertension experts surveyed were convinced of the efficacy and safety of RDN based on the preponderance of available scientific and clinical data. Identification of the ideal patient group remains controversial. Respondents generally agreed on the necessity of building close collaborative relationships between interventionalists and hypertension experts in order to improve RDN clinical outcome. (c) 2021 Hellenic Society of Cardiology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)." }